The estimated Net Worth of Investment Management, Ltd.... is at least $50.4 million dollars as of 25 October 2021. Investment Ltd owns over 647,862 units of Enfusion stock worth over $40,050,223 and over the last 9 years Investment sold ENFN stock worth over $10,301,006.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Investment Ltd ENFN stock SEC Form 4 insiders trading
Investment has made over 2 trades of the Enfusion stock since 2016, according to the Form 4 filled with the SEC. Most recently Investment sold 647,862 units of ENFN stock worth $10,301,006 on 25 October 2021.
The largest trade Investment's ever made was buying 9,100,000 units of Enfusion stock on 8 February 2016 worth over $73,255,000. On average, Investment trades about 3,249,287 units every 695 days since 2016. As of 25 October 2021 Investment still owns at least 4,975,183 units of Enfusion stock.
You can see the complete history of Investment Ltd stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Investment Ltd's mailing address?
Investment's mailing address filed with the SEC is OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN, E9, KY1-9006.
Insiders trading at Enfusion
Over the last 3 years, insiders at Enfusion have traded over $144,301,080 worth of Enfusion stock and bought 2,523,188 units worth $42,894,196 . The most active insiders traders include Investment Management, Ltd...., Bradford Eftv Iv, L.P. Bern... et Tarek Lra Ventures, Llc Ham.... On average, Enfusion executives and independent directors trade stock every 22 days with the average trade being worth of $2,488,344. The most recent stock trade was executed by Valeria Gutowski on 18 June 2024, trading 1,258 units of ENFN stock currently worth $10,278.
What does Enfusion's logo look like?
Complete history of Investment Ltd stock trades at BeiGene Ltd et Enfusion
Enfusion executives and stock owners
Enfusion executives and other stock owners filed with the SEC include:
-
Bronwen Bastone,
Chief People Officer -
Lorelei M. Skillman,
Chief Marketing Officer -
Brian Murphy,
Investor -
Daniel Groman,
MD & CTO -
Alan Polo,
Head of Account Management -
Michael Berry,
Chief Operating Officer -
Stephen P. Dorton,
Chief Financial Officer -
Stephen Malherbe,
Managing Partner -
Thomas Kim,
Chief Exec. Officer -
Tarek Hammoud,
Co-Founder & Exec. Chairman -
Steven M. Bachert,
Chief Revenue Officer -
Bradley Herring,
Chief Financial Officer -
Michael Spellacy,
Director -
Deirdre Somers,
Director -
Matthew Campobasso,
General Counsel -
Neal Pawar,
Chief Operating Officer -
Stephen Malherbe Investment...,
-
Lawrence E Leibowitz,
Director -
Bradford Eftv Iv, L.P. Bern...,
-
Oleg Movchan,
Director -
Oleg Csl Tech Holdings Llc ...,
Chief Executive Officer -
Investment Management, Ltd....,
10% owner -
Tarek Hammoud,
Director -
Strategic Partners V, L.P.I...,
-
Roy Luo,
Director -
Jan Hauser,
Director -
Kathleen De Rose,
Director -
Thomas Kim,
Chief Executive Officer -
Lorelei M. Skillman,
Chief Mrktg. & Comm. Officer -
Stephen M Dorton,
Chief Financial Officer -
Bronwen Bastone,
Chief People Officer -
Dan Groman,
Chief Technology Officer -
Tarek Lra Ventures, Llc Ham...,
-
Oleg Quiet Light Securities...,
Chief Executive Officer -
Valeria Gutowski,
Chief Accounting Officer